Das, Anindita <br/><br/>
ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  May 2009 
 - H1236-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00100.2009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiovascular Agents--pharmacology<br/>Cyclic GMP-Dependent Protein Kinases--metabolism<br/>Cyclic Nucleotide Phosphodiesterases, Type 5--metabolism<br/>Disease Models, Animal<br/>Enzyme Activation<br/>Flavonoids--pharmacology<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Hemodynamics--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3--antagonists & inhibitors<br/>Myocardial Contraction--drug effects<br/>Myocardial Infarction--enzymology<br/>Myocardial Reperfusion Injury--enzymology<br/>Myocardium--enzymology<br/>Nitric Oxide Synthase Type II--metabolism<br/>Nitric Oxide Synthase Type III--metabolism<br/>Phosphodiesterase 5 Inhibitors<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Phosphorylation<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Purines--pharmacology<br/>Signal Transduction--drug effects<br/>Sildenafil Citrate<br/>Sulfones--pharmacology<br/>Time Factors<br/>bcl-2-Associated X Protein--metabolism